Grants for Private institutions of higher education - Federal

This funding opportunity provides financial support for state and local governments, educational institutions, nonprofits, and tribal organizations to advance plant conservation and restoration projects in Colorado, focusing on biodiversity and climate resilience.

This funding opportunity provides financial assistance to state, Tribal, and local governments in EPA Region 3 to develop and improve wetland protection programs that enhance wetland health and increase wetland areas.

This grant provides funding to support a centralized technical assistance center that will help state vocational rehabilitation agencies improve services and employment outcomes for individuals with disabilities.

This funding opportunity provides financial support to research centers focused on improving interventions and services for children and adolescents with autism and developmental disabilities across the United States.

The "U.S. Nuclear Regulatory Commission Minority Serving Institutions Grant Program, Scholarships and Fellowships, Fiscal Year 2024" is a funding opportunity aimed at providing scholarships and fellowships to Minority Serving Institutions for the purpose of enhancing knowledge and skills in nuclear safety, security, environmental protection, and other fields critical to the Commission's mission.

This funding opportunity provides financial support to early-career academic scientists and engineers in the U.S. to advance research relevant to the Navy's science and technology priorities.

The "OSERS-OSEP: Personnel Preparation of Special Education, Early Intervention, and Related Services Personnel" grant is a funding opportunity from the U.S. Department of Education aimed at increasing the number of qualified, diverse professionals in special education and early intervention fields, by providing financial support for their training at minority-serving institutions, with the ultimate goal of improving services and outcomes for children with high-intensity disabilities.

This grant provides funding for researchers to conduct innovative studies on ovarian cancer, focusing on impactful solutions that benefit patients and their families.

This funding opportunity provides financial support to community coalitions that have previously received DFC grants, enabling them to implement strategies to prevent and reduce substance use among youth.

The Department of States Office to Monitor and Combat Trafficking in Persons (TIP Office) announces an open competition for projects in support of a forthcoming Child Protection Compact (CPC) Partnership between the United States and the Government of Romania.

This funding opportunity supports U.S.-based non-profit organizations partnering with overseas schools, libraries, and hospitals to promote American values and enhance institutional capacity through projects that foster mutual understanding and public diplomacy.

This grant provides funding to organizations that engage AmeriCorps members in service projects addressing community needs, particularly in rural, tribal, and high-poverty areas, while focusing on priorities like youth mental health, public safety, and workforce development.

This program provides funding to support collaborations between formal methods researchers and experts in various computer and engineering fields to improve system design and reliability through innovative methodologies and educational initiatives.

The United States Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) Wildlife Services (WS) is announcing the availability of around $5,500,000 in cooperative agreement funding to control and prevent chronic wasting disease (CWD) in wild cervids. The amount available will be based on the amount appropriated by Congress less administrative costs. Proposals may further develop and implement wild CWD surveillance, testing, management, and response activities, including further development and evaluation of techniques and strategies to prevent or control CWD in wild cervids. WS intends to achieve a balance between management and research proposals. USDA APHIS Wildlife Services (WS) is also announcing the availability of cooperative agreement funding for a separate funding opportunity for the control and prevention of CWD in wild cervids on Tribal lands under the title “FY24 Tribal Nations Wild Cervid CWD Opportunities”. These funds will be made available for Federally recognized Native American Tribal governments. Once posted, applicants can find this funding opportunity information on the ezFedGrants website or the Grants.gov website by searching this title, the Catalog of Federal Domestic Assistance Number (CFDA) Number 10.028, or the Funding Opportunity Number USDA-APHIS-10028-WSNWRC00-24-0005. USDA APHIS Veterinary Services (VS) is announcing a separate funding opportunity for the control and prevention of CWD in farmed cervids under the title “FY24 Farmed Cervid CWD Management and Response Activities.” Applicants can find this funding opportunity information on the ezFedGrants website or the Grants.gov website by searching this title, the CFDA number 10.025, or the Funding Opportunity Number USDA-APHIS-10025-VSSPRS00-24-0007.

MDF is NICs Management Development for the Future series, a dynamic, agency exclusive, individual and organizational development experience, which primarily targets the middle management tier of a correctional organization. This established curriculum simultaneously engages all levels of agency leadership through internal action-based learning strategies at the individual, team and agency levels.This agency exclusive leadership development series is conducted over up to 12+ months and is provided to participants within selected partner agencies. The learning strategies used in this blended and hybrid delivery individual and organizational development series include three phases one in person 24 - hour (3 in-person days) and two fully virtual phases (seven, 3-hour virtual instructor led sessions with intersession activities between virtual sessions), each delivered approximately 4 - 5 months apart. Participants will prepare a dynamic leadership development plan, participate in individual developmental coaching, and during intercession periods between phases undertake action-based learning projects1 Campbell, Nancy M. Correctional Leadership Competencies for the 21stCentury: Executives and Senior-Level Leaders, July 2005, Retrieved from https://s3.amazonaws.com/static.nicic.gov/Library/020474.pdf2 Day, David V., John W. Fleenor, Leanna E. Atwater, Rachel E. Sturm, and Rob A. McKee. "Advances in Leader and Leadership Development: A Review of 25 Years of Research and Theory." The Leadership Quarterly 25, no. 1 (February 2014): 63-82.3 Zenger, Jack, and Joe Folkman. "Leadership Development 6.0: Connecting Leadership Development with Drivers of Business Results." Zenger Folkman, 2010. UT: Orem24AC07focused on the relevant issues in their agencies with the intention of applying skills and strategies learned in the program to build organizational capacity and manage organizational change between phases ones, two and three. The blended and hybrid MDF series simultaneously engages all levels of agency leadership through internal action-based learning strategies at the individual, team and agency levels.Pre-session activities prior to each phase include participants completing several online instruments, reading assignments and other required activities. This program is grounded in the evidence based Full Range Leadership Model developed by Bass, B. M., and Avolio, B. J. An on-line 360-degree feedback instrument assesses the participants behavior against the model.A proposal responsive to this solicitation should provide substantiated documentation of: 1) respondent organizational capacity and project management expertise and experience to manage multiple, overlapping projects simultaneously; 2) a minimum of 10 years of experience managing national and regional training events in corrections settings; 3) 10 years of substantiated experience setting up, hosting, producing and facilitating blended (virtual instructor led platforms) and face to face training series; 4) 10 years of substantiated experience facilitating blended and face to face leader training with correctional agencies (jails, prisons, community corrections); 5) proposed faculty with 10 years minimum experience, credentials and qualifications to administer, interpret and facilitate the Multifactor Leadership Questionnaire II, FIRO-B Interpretative Report for Organizations, Thomas-Kilman Conflict Mode Indicator and other instrumentation as needed based upon partner agency needs and their applications to corrections settings; 6) 10 years experience for proposed faculty to perform developmental leadership coaching; 7) 10 years experience facilitating experiential leadership training activities and tying them through content and leadership competencies to on the job leadership correctional applications; and 8) 10 years of experience working with executive and senior level leaders in correctional agencies on organizational development initiatives which advance agencies mission, vision and values.

This funding opportunity provides financial support to U.S. and Jordan-based nonprofit organizations and educational institutions to organize a two-day education fair promoting U.S. higher education to Jordanian students and their families.

This funding opportunity supports early-career scientists conducting innovative research to improve the understanding, diagnosis, treatment, or prevention of mental health disorders.

The FY24 PCRP Exploration Hypothesis Development Award supports the exploration of highly innovative, untested, potentially high-gain concepts, theories, paradigms, and/or methods that address an important problem relevant to one or more of the FY24 PCRP Overarching Challenges. This award is designed to provide investigators the opportunity to pursue serendipitous observations that may reveal entirely new avenues for investigation. Results of studies conducted through this award may provide the scientific premise upon which a new hypothesis can be based or initial proof of principle of an innovative hypothesis, laying the groundwork for future avenues of scientific investigation. Presentation of preliminary data is inconsistent with the intent of this award mechanism and is therefore strongly discouraged. However, logical reasoning and a sound scientific rationale for the proposed work must be described. Reviewers will be blinded to the identity of the Principal Investigator (PI), collaborator(s), and their organization(s). Refer to Section II.D.2.b.i, Full Application Submission Type, for more information. New for FY24: Clinical research is allowed. For the purposes of this funding opportunity, research that meets the definition of a clinical trial is distinct from clinical research. Clinical research encompasses research with human data, human specimens, and/or interaction with human subjects. Clinical research is observational in nature and includes: (1) Research conducted with human subjects and/or material of human origin such as data, specimens, and cognitive phenomena for which an investigator (or co-investigator) does not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention. Research meeting this definition may include but is not limited to: (a) mechanisms of human disease, (b) diagnostic or detection studies (e.g., biomarker or imaging), (c) health disparity studies, and (d) development of new technologies. (2) Epidemiologic and behavioral studies that do not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention. (3) Outcomes research and health services research that do not fit under the definition of clinical trial. Excluded from the definition of clinical research are in vitro studies that utilize human data or specimens that cannot be linked to a living individual and meet the requirements for exemption under 46.104(d)(4) of the Common Rule. Clinical trials are not allowed. A clinical trial is defined in the Code of Federal Regulations, Title 45, Part 46.102 (45 CFR 46.102) as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include a placebo or another control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes. Studies that do not seek to measure safety, effectiveness, and/or efficacy outcome(s) of an intervention are not considered clinical trials. A congressionally mandated Metastatic Cancer Task Force was formed with the purpose of identifying ways to help accelerate clinical and translational research aimed at extending the lives of advanced state and recurrent patients. As a member of the Metastatic Cancer Task Force, the CDMRP encourages applicants to review the recommendations (https://health.mil/Reference-Center/Congressional-Testimonies/2018/05/03/Metastatic-Cancer Research) and submit research ideas to address these recommendations provided they are within the limitations of this funding opportunity and fit within the FY24 PCRP priorities. Innovative research involving nuclear medicine and related techniques to support early diagnosis, more-effective treatment, and improved health outcomes of active-duty Service Members and their Families is encouraged. Such research could improve diagnostic and targeted treatment capabilities through noninvasive techniques and may drive the development of precision imaging and advanced targeted therapies. Applications from investigators within the military services and applications involving multidisciplinary collaborations among academia, industry, the military services, the U.S. Department of Veterans Affairs (VA), and other federal government agencies are highly encouraged. These relationships can leverage knowledge, infrastructure, and access to unique clinical populations that the collaborators bring to the research effort, ultimately advancing research that is of significance to Service Members, Veterans, and/or their Families. If the proposed research relies on access to unique resources or databases, the application must describe the access at the time of submission and include a plan for maintaining access as needed throughout the proposed research. All projects should adhere to a core set of standards for rigorous study design and reporting to maximize the reproducibility and translational potential of clinical and preclinical research. The standards are described in SC Landis et al., 2012, A call for transparent reporting to optimize the predictive value of preclinical research, Nature 490:187-191 (https://www.nature.com/nature/ journal/v490/n7419/full/nature11556.html). While these standards are written for preclinical studies, the basic principles of randomization, blinding, sample-size estimation, and data handling derive from well-established best practices in clinical studies. The funding instrument for awards made under the program announcement will be grants (31 USC 6304). The anticipated direct costs budgeted for the entire period of performance for an FY24 Exploration Hypothesis Development Award should not exceed $150,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information. Awards supported with FY24 funds will be made no later than September 30, 2025. The CDMRP expects to allot approximately $3.60M to fund approximately 15 Exploration Hypothesis Development Award applications. Funding of applications received is contingent upon the availability of federal funds for this program, the number of applications received, the quality and merit of the applications as evaluated by peer and programmatic review, and the requirements of the government. Funds to be obligated on any award resulting from this funding opportunity will be available for use for a limited time period based on the fiscal year of the funds. It is anticipated that awards made from this FY24 funding opportunity will be funded with FY24 funds, which will expire for use on September 30, 2030. Research Involving Animals: All research funded by the FY24 PCRP Exploration-Hypothesis Development Award involving new and ongoing research with animals must be reviewed and approved by the USAMRDC Office of Human and Animal Research Oversight (OHARO; previously the Human Research Protection Office), Animal Care and Use Review Office (ACURO), in addition to the local Institutional Animal Care and Use Committee (IACUC) of record. IACUC approval at the time of submission is not required. Allow at least 3 to 4 months for ACURO regulatory review and approval processes for animal studies. Refer to the General Application Instructions for additional information.

This grant provides funding for collaborative projects among archivists and institutions to improve the processing, preservation, and access to Congressional Records collections across the United States.

To obtain a copy of the Funding Opportunity Announcement (FOA) please go to the ARPA-E website at https://arpa-e-foa.energy.gov. To apply to this FOA, Applicants must register with and submit application materials through ARPA-E eXCHANGE (https://arpa-e-foa.energy.gov/Registration.aspx). For detailed guidance on using ARPA-E eXCHANGE, please refer to the ARPA-E eXCHANGE User Guide (https://arpa-e-foa.energy.gov/Manuals.aspx). ARPA-E will not review or consider concept papers submitted through other means. For problems with ARPA-E eXCHANGE, email [email protected] (with FOA name and number in the subject line). Questions about this FOA? Check the Frequently Asked Questions available at http://arpa-e.energy.gov/faq. For questions that have not already been answered, email [email protected]. The purpose of this modification is to incorporate changes to Funding Opportunity Announcement. Accordingly, this modification: Inserted new Exploratory Topic, Topic M: H2SENSE. See Table 1. Exploratory Topics, Appendix M, and Total Amounts to be awarded on Cover Page. Updated Language in Appendix L Section 5.